These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16135370)

  • 21. Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation.
    Yamamura K; Sasaki H; Nakashima M; Ichikawa M; Mukai T; Nishida K; Nakamura J
    Pharm Res; 1999 Oct; 16(10):1596-601. PubMed ID: 10554103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests.
    Sutinen R; Paronen P; Urtti A
    Eur J Pharm Sci; 2000 Jul; 11(1):19-24. PubMed ID: 10913749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations.
    Grégoire S; Ribaud C; Benech F; Meunier JR; Garrigues-Mazert A; Guy RH
    Br J Dermatol; 2009 Jan; 160(1):80-91. PubMed ID: 18811683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal timolol delivery from a Pluronic gel.
    Stamatialis DF; Rolevink HH; Koops GH
    J Control Release; 2006 Nov; 116(2):e53-5. PubMed ID: 17718968
    [No Abstract]   [Full Text] [Related]  

  • 26. Finite dose percutaneous drug absorption: a BASIC program for the solution of the diffusion equation.
    Kubota K
    Comput Biomed Res; 1991 Apr; 24(2):196-207. PubMed ID: 1903685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics.
    Hada N; Hasegawa T; Takahashi H; Ishibashi T; Sugibayashi K
    J Control Release; 2005 Nov; 108(2-3):341-50. PubMed ID: 16226333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multiple-pathway model for the diffusion of drugs in skin.
    Lee AJ; King JR; Rogers TG
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):127-50. PubMed ID: 8671583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol.
    Kubota K; Koyama E; Twizell EH
    J Pharm Sci; 1993 Dec; 82(12):1205-8. PubMed ID: 8308696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ophthalmic mucoadhesive vehicles: preliminary study of ocular pharmacokinetics "in vivo"].
    Chetoni P; Vigetti B; Perini G; Saettone MF
    Boll Chim Farm; 1996 Feb; 135(2):147-9. PubMed ID: 9044564
    [No Abstract]   [Full Text] [Related]  

  • 32. A sequential algorithm for the non-linear dual-sorption model of percutaneous drug absorption.
    Gumel AB; Kubota K; Twizell EH
    Math Biosci; 1998 Aug; 152(1):87-103. PubMed ID: 9727298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor.
    Volotinen M; Mäenpää J; Kautiainen H; Tolonen A; Uusitalo J; Ropo A; Vapaatalo H; Aine E
    Eur J Pharm Sci; 2009 Feb; 36(2-3):292-6. PubMed ID: 19013521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
    Wen Z; Fang L; He Z
    Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of sucrose fatty acid esters in transdermal therapeutic systems.
    Csóka G; Marton S; Zelko R; Otomo N; Antal I
    Eur J Pharm Biopharm; 2007 Feb; 65(2):233-7. PubMed ID: 16963242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Numerical Investigation of Analytical Models of Drug Flux Through Microporated Skin.
    Pavlov AM; Rzhevskiy AS; Anissimov YG
    J Pharm Sci; 2019 Jan; 108(1):358-363. PubMed ID: 30439461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel transdermal delivery of Timolol maleate using sugar esters: preclinical and clinical studies.
    El-Laithy HM
    Eur J Pharm Biopharm; 2009 May; 72(1):239-45. PubMed ID: 19126429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin.
    Mills PC; Magnusson BM; Cross SE
    Vet J; 2006 Mar; 171(2):276-80. PubMed ID: 16490709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.